Recurrent Gynecological Cancer
1 clinical trials · Condition
◉ Watch Recurrent Gynecological Cancer
| Record | Firm | Date |
|---|---|---|
| Durvalumab, Tremelimumab + Radiotherapy in Gynecologic Cancer (NCT03277482) | Dana-Farber Cancer Institute | 2018-06-01 |
Track Recurrent Gynecological Cancer automatically
Every clearance here is in the API, with alerts when new ones post.